In accordance with this notion, target gene studies reveal that ERα and ERβ may have distinct biological functions; it is believed that ERα promotes cell growth, while ERβ inhibits it in breast and prostate cancer cells [11], [14], [16], [17], [18], [19]. The gene discussed is ESR1; the disease is prostate carcinoma.